HOPE STEPHENS: Open Payments
NPI 1376127308 · MT JULIET, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,003 in 36 payments from 13 companies in 2025. Trend: 2023 $171 · 2024 $250 · 2025 $1,003
Food & beverage: $1,003
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $241 |
| GlaxoSmithKline, LLC. | 4 | $167 |
| GENZYME CORPORATION | 3 | $150 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $114 |
| CSL Behring | 4 | $71 |
| Grifols USA, LLC | 3 | $61 |
| Ionis Pharmaceuticals, Inc. | 3 | $49 |
| Genentech USA, Inc. | 2 | $38 |
| Lilly USA, LLC | 1 | $28 |
| Cycle Pharmaceuticals Inc | 1 | $27 |
Products named: DUPIXENT, NUCALA, AIRSUPRA, NEFFY, FASENRA, Xembify, Xolair, Andembry.
Industry payments across TN — which companies pay providers there.
